Spring Bank: F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals

(marketscreener.com) CAMBRIDGE, England and CAMBRIDGE, Mass., Nov. 20, 2020 /PRNewswire/ -- F-star Therapeutics, Inc., a clinical-stage immuno-oncology company determined to transform the lives of patients with cancer through the development of innovative tetravalent mAb2 bispecific antibodies, today announced the completion of its business combination...https://www.marketscreener.com/news/latest/F-star-Therapeutics-Completes-Combination-with-Spring-Bank-Pharmaceuticals--31839386/?utm_medium=RSS&utm_content=20201120